Gilead Sciences PE Ratio 2006-2018 | GILD

Current and historical p/e ratio for Gilead Sciences (GILD) from 2006 to 2018. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Gilead Sciences PE ratio as of October 22, 2018 is 10.41.
Gilead Sciences PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2018-10-22 72.34 43.58
2018-06-30 70.84 $1.66 42.67
2018-03-31 74.79 $2.60 28.77
2017-12-31 70.56 $3.48 20.28
2017-09-30 79.25 $8.78 9.03
2017-06-30 68.80 $9.21 7.47
2017-03-31 65.49 $9.46 6.92
2016-12-31 68.53 $9.94 6.89
2016-09-30 75.24 $10.78 6.98
2016-06-30 78.85 $11.35 6.95
2016-03-31 86.35 $11.69 7.39
2015-12-31 94.67 $11.92 7.94
2015-09-30 91.23 $10.92 8.35
2015-06-30 108.64 $9.53 11.40
2015-03-31 90.72 $8.81 10.30
2014-12-31 87.14 $7.38 11.81
2014-09-30 98.41 $5.67 17.36
2014-06-30 76.65 $4.47 17.15
2014-03-31 65.51 $2.73 24.00
2013-12-31 69.43 $1.83 37.94
2013-09-30 58.12 $1.83 31.76
2013-06-30 47.40 $1.79 26.55
2013-03-31 45.25 $1.79 25.35
2012-12-31 33.95 $1.65 20.64
2012-09-30 30.66 $1.61 19.04
2012-06-30 23.70 $1.66 14.28
2012-03-31 22.59 $1.67 13.56
2011-12-31 18.92 $1.78 10.66
2011-09-30 17.94 $1.72 10.43
2011-06-30 19.14 $1.66 11.53
2011-03-31 19.63 $1.59 12.35
2010-12-31 16.75 $1.65 10.15
2010-09-30 16.46 $1.71 9.65
2010-06-30 15.85 $1.65 9.60
2010-03-31 21.02 $1.56 13.47
2009-12-31 20.00 $1.42 14.14
2009-09-30 21.49 $1.28 16.79
2009-06-30 21.65 $1.18 18.35
2009-03-31 21.41 $1.11 19.38
2008-12-31 23.64 $1.05 22.62
2008-09-30 21.09 $0.95 22.20
2008-06-30 24.48 $0.90 27.20
2008-03-31 23.82 $0.88 27.07
2007-12-31 21.27 $0.84 25.39
2007-09-30 18.89 $-0.27 0.00
2007-06-30 17.94 $-0.51 0.00
2007-03-31 17.72 $-0.58 0.00
2006-12-31 15.01 $-0.66 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $93.777B $26.107B
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The Company strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions. Their portfolio of marketed products includes a number of category firsts, including complete treatment regimens for HIV infection available in a once-daily single pill and the first oral antiretroviral pill available to reduce the risk of acquiring HIV infection in certain high-risk adults.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $128.173B 14.71
Biogen (BIIB) United States $63.563B 13.47
Celgene (CELG) United States $56.698B 11.32
Illumina (ILMN) United States $46.633B 58.42
Vertex Pharmaceuticals (VRTX) United States $45.336B 103.14
Regeneron Pharmaceuticals (REGN) United States $41.904B 23.56
Alexion Pharmaceuticals (ALXN) United States $27.617B 20.76
BioMarin Pharmaceutical (BMRN) United States $18.386B 0.00
Incyte (INCY) United States $13.856B 465.57
Seattle Genetics (SGEN) United States $11.303B 0.00
Sarepta Therapeutics (SRPT) United States $8.808B 0.00
QIAGEN (QGEN) Netherlands $8.121B 26.55
Exact Sciences (EXAS) United States $7.641B 0.00
Alnylam Pharmaceuticals (ALNY) United States $7.545B 0.00
Bio-Techne Corp (TECH) United States $6.821B 45.62
Bluebird Bio (BLUE) United States $6.355B 0.00
BeiGene (BGNE) Cayman Islands $6.314B 0.00
Alkermes (ALKS) Ireland $6.036B 0.00
Amarin (AMRN) Ireland $5.785B 0.00
Galapagos (GLPG) Belgium $5.528B 0.00
Exelixis (EXEL) United States $4.605B 15.00
Immunomedics (IMMU) United States $4.428B 0.00
Ligand Pharmaceuticals (LGND) United States $3.902B 34.56
Myriad Genetics (MYGN) United States $3.266B 34.69
Horizon Pharma Public (HZNP) Ireland $3.206B 18.15
Array BioPharma (ARRY) United States $3.164B 0.00
GUARDANT HEALTH (GH) United States $3.126B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.111B 0.00
Emergent Biosolutions (EBS) United States $3.060B 24.38
Blueprint Medicines (BPMC) United States $3.039B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $2.988B 0.00
Ascendis Pharma (ASND) Denmark $2.865B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.720B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.720B 0.00
ARGENX SE-ADR (ARGX) Netherlands $2.675B 0.00
ALLOGENE THERPS (ALLO) United States $2.650B 0.00
Repligen (RGEN) United States $2.457B 82.47
Genomic Health (GHDX) United States $2.361B 131.68
China Biologic Products (CBPO) China $2.336B 16.06
Acceleron Pharma (XLRN) United States $2.316B 0.00
Halozyme Therapeutics (HALO) United States $2.263B 30.15
Amicus Therapeutics (FOLD) United States $2.241B 0.00
MyoKardia (MYOK) United States $2.224B 0.00
Global Blood Therapeutics (GBT) United States $2.003B 0.00
Medicines (MDCO) United States $1.962B 0.00
Arena Pharmaceuticals (ARNA) United States $1.931B 0.00
REGENXBIO (RGNX) United States $1.895B 29.78
Akcea Therapeutics (AKCA) United States $1.894B 0.00
Allakos (ALLK) United States $1.876B 0.00
Cambrex (CBM) United States $1.861B 14.92
AnaptysBio (ANAB) United States $1.836B 0.00
Reata Pharmaceuticals (RETA) United States $1.746B 0.00
Spark Therapeutics (ONCE) United States $1.720B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.702B 0.00
CRISPR THERAPTC (CRSP) Switzerland $1.674B 0.00
Innoviva (INVA) United States $1.603B 10.29
Aimmune Therapeutics (AIMT) United States $1.574B 0.00
Atara Biotherapeutics (ATRA) United States $1.547B 0.00
Puma Biotechnology (PBYI) United States $1.536B 0.00
Denali Therapeutics (DNLI) United States $1.469B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.454B 0.00
WAVE Life Sciences (WVE) Singapore $1.371B 0.00
Rubius Therapeutics (RUBY) United States $1.362B 0.00
Sangamo Therapeutics (SGMO) United States $1.328B 0.00
Myovant Sciences (MYOV) United Kingdom $1.322B 0.00
G1 THERAPEUTICS (GTHX) United States $1.321B 0.00
Editas Medicine (EDIT) United States $1.278B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.272B 0.00
Solid Biosciences (SLDB) United States $1.249B 0.00
Insmed (INSM) United States $1.247B 0.00
IMMURON LTD (IMRN) Australia $1.155B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.145B 2186.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.129B 0.00
NeoGenomics (NEO) United States $1.115B 195.14
Clovis Oncology (CLVS) United States $1.112B 0.00
Mirati Therapeutics (MRTX) United States $1.101B 0.00
Cellectis (CLLS) France $1.087B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.078B 0.00
DBV Technologies (DBVT) France $1.065B 0.00
Retrophin (RTRX) United States $1.033B 0.00
Audentes Therapeutics (BOLD) United States $1.008B 0.00
UniQure (QURE) Netherlands $0.982B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $0.955B 0.00
Intellia Therapeutics (NTLA) United States $0.952B 0.00
Intra-Cellular Therapies (ITCI) United States $0.942B 0.00
Lion Biotechnologies (IOVA) United States $0.940B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.938B 0.00
Aptinyx (APTX) United States $0.875B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.867B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.865B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.853B 0.00
Revance Therapeutics (RVNC) United States $0.853B 0.00
Athenex (ATNX) United States $0.835B 0.00
Acorda Therapeutics (ACOR) United States $0.828B 17.26
Viking Therapeutics (VKTX) United States $0.821B 0.00
Coherus BioSciences (CHRS) United States $0.820B 0.00
InflaRx (IFRX) Germany $0.784B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.773B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.763B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.762B 0.00
Heska (HSKA) United States $0.761B 65.52
Cara Therapeutics (CARA) United States $0.757B 0.00
Dynavax Technologies (DVAX) United States $0.757B 0.00
Apellis Pharmaceuticals (APLS) United States $0.747B 0.00
Novavax (NVAX) United States $0.731B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.713B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.709B 0.00
CytomX Therapeutics (CTMX) United States $0.669B 0.00
AVROBIO (AVRO) United States $0.664B 0.00
Epizyme (EPZM) United States $0.655B 0.00
ANI Pharmaceuticals (ANIP) United States $0.650B 12.87
Fate Therapeutics (FATE) United States $0.637B 0.00
Mesoblast (MESO) Australia $0.636B 0.00
ObsEva SA (OBSV) Switzerland $0.625B 0.00
AC Immune SA (ACIU) Switzerland $0.600B 0.00
MiMedx (MDXG) United States $0.587B 25.19
Scholar Rock Holding (SRRK) United States $0.576B 0.00
Anika Therapeutics (ANIK) United States $0.576B 24.24
NuCana Sponsored ADR (NCNA) United Kingdom $0.576B 0.00
UROGEN PHARMA (URGN) Israel $0.567B 0.00
Arcus Biosciences (RCUS) United States $0.545B 0.00
RA PHARMCTL INC (RARX) United States $0.542B 0.00
Principia Biopharma (PRNB) United States $0.540B 0.00
Prothena (PRTA) Ireland $0.504B 0.00
Kezar Life Sciences (KZR) United States $0.492B 0.00
Stemline Therapeutics (STML) United States $0.486B 0.00
Vericel (VCEL) United States $0.482B 0.00
Inovio Pharmaceuticals (INO) United States $0.481B 0.00
ARVINAS INC (ARVN) United States $0.476B 0.00
Five Prime Therapeutics (FPRX) United States $0.475B 0.00
UNITY Biotechnology (UBX) $0.463B 0.00
Abeona Therapeutics (ABEO) United States $0.451B 0.00
MediciNova (MNOV) United States $0.445B 0.00
Kura Oncology (KURA) United States $0.443B 0.00
GRITSTONE ONCLG (GRTS) United States $0.437B 0.00
Senesco Technologies (ELOX) United States $0.432B 0.00
Sinovac Biotech (SVA) China $0.428B 0.00
Kindred Biosciences (KIN) United States $0.426B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.420B 0.00
Verastem (VSTM) United States $0.415B 0.00
BeyondSpring (BYSI) United States $0.413B 0.00
Zealand Pharma (ZEAL) Denmark $0.412B 0.00
Zymeworks (ZYME) Canada $0.401B 0.00
Cytokineticsorporated (CYTK) United States $0.390B 0.00
Sorrento Therapeutics (SRNE) United States $0.390B 66.80
Liquidia Technologies (LQDA) United States $0.379B 0.00
UROVANT SCIENCS (UROV) United States $0.378B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.375B 0.00
Replimune (REPL) United States $0.370B 0.00
PDL BioPharma (PDLI) United States $0.369B 5.18
Osiris Therapeutics (OSIR) United States $0.363B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.362B 0.00
KODIAK SCIENCES (KOD) United States $0.361B 0.00
Eidos Therapeutics (EIDX) United States $0.357B 0.00
MeiraGTx Holdings (MGTX) United States $0.354B 0.00
Aduro Biotech (ADRO) United States $0.350B 0.00
Merus (MRUS) Netherlands $0.346B 0.00
Albireo Pharma (ALBO) United States $0.339B 0.00
SUTRO BIOPHARMA (STRO) United States $0.330B 0.00
Magenta Therapeutics (MGTA) United States $0.327B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.314B 0.00
ResTORbio (TORC) United States $0.309B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.309B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.309B 0.00
Evelo Biosciences (EVLO) United States $0.308B 0.00
Geron (GERN) United States $0.301B 0.00
Kala Pharmaceuticals (KALA) United States $0.298B 0.00
Selecta Biosciences (SELB) United States $0.298B 0.00
Celcuity (CELC) United States $0.295B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.292B 0.00
MannKind (MNKD) United States $0.286B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.285B 0.00
Athersys (ATHX) United States $0.280B 0.00
Adverum Biotechnologies (ADVM) United States $0.277B 0.00
Cellular Biomedicine (CBMG) United States $0.273B 0.00
Seres Therapeutics (MCRB) United States $0.269B 0.00
Kadmon Holdings (KDMN) United States $0.269B 0.00
Unum Therapeutics (UMRX) United States $0.266B 0.00
Proteostasis Therapeutics (PTI) United States $0.264B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.261B 0.00
Axovant Sciences (AXON) United Kingdom $0.258B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.256B 0.00
Celyad SA (CYAD) Belgium $0.256B 0.00
ADMA Biologics Inc (ADMA) United States $0.255B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.253B 0.00
BioTime (BTX) United States $0.252B 0.00
Arbutus Biopharma (ABUS) Canada $0.240B 0.00
EQUILLIUM INC (EQ) United States $0.240B 0.00
Syros Pharmaceuticals (SYRS) United States $0.239B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.234B 0.00
TOCAGEN INC (TOCA) United States $0.233B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.233B 0.00
Kamada (KMDA) Israel $0.232B 18.00
Krystal Biotech (KRYS) United States $0.232B 0.00
Synlogic (SYBX) United States $0.224B 0.00
Strongbridge Biopharma (SBBP) United States $0.222B 0.00
Allena Pharmaceuticals (ALNA) United States $0.212B 0.00
BioDelivery Sciences (BDSI) United States $0.209B 0.00
NantKwest (NK) United States $0.206B 0.00
Agenus (AGEN) United States $0.205B 0.00
Idera Pharmaceuticals (IDRA) United States $0.200B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.199B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.199B 0.00
ChromaDex (CDXC) United States $0.197B 0.00
Protagonist Therapeutics (PTGX) United States $0.194B 0.00
Palatin Technologies (PTN) United States $0.184B 7.61
Compugen (CGEN) Israel $0.177B 0.00
Constellation Pharmaceuticals (CNST) United States $0.176B 0.00
Cerecor (CERC) United States $0.175B 17.92
Mersana Therapeutics (MRSN) United States $0.173B 0.00
Cohbar (CWBR) United States $0.173B 0.00
Enzo Biochem (ENZ) United States $0.173B 0.00
Clearside Biomedical (CLSD) United States $0.170B 0.00
Intec Pharma (NTEC) Israel $0.170B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.168B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.159B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.155B 0.00
Spero Therapeutics (SPRO) United States $0.153B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.152B 0.00
OVID THERAPEUTC (OVID) United States $0.148B 0.00
Signal Genetics (MGEN) United States $0.141B 0.00
Pfenex (PFNX) United States $0.140B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.139B 0.00
VBI Vaccines (VBIV) United States $0.136B 0.00
Cue Biopharma (CUE) United States $0.136B 0.00
Pluristem Therapeutics (PSTI) Israel $0.134B 0.00
Menlo Therapeutics (MNLO) United States $0.134B 0.00
PSivida (EYPT) United States $0.132B 0.00
VTv Therapeutics (VTVT) United States $0.129B 0.00
XBiotech (XBIT) United States $0.123B 0.00
XOMA (XOMA) United States $0.123B 12.97
Organovo Holdings (ONVO) United States $0.123B 0.00
Eleven Biotherapeutics (SESN) United States $0.122B 0.00
Monster Digital (INNT) United States $0.122B 0.00
Mustang Bio (MBIO) United States $0.122B 0.00
CorMedix Inc (CRMD) United States $0.120B 0.00
Motif Bio Plc (MTFB) United States $0.118B 0.00
Tapimmune (MRKR) United States $0.118B 0.00
Applied Genetic Technologies (AGTC) United States $0.117B 0.00
Anavex Life Sciences (AVXL) United States $0.115B 0.00
Catalyst Biosciences (CBIO) United States $0.112B 0.00
OncoSec Medical (ONCS) United States $0.106B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.105B 0.00
Cidara Therapeutics (CDTX) United States $0.104B 0.00
Provention Bio (PRVB) United States $0.104B 0.00
Axsome Therapeutics (AXSM) United States $0.103B 0.00
VolitionRX (VNRX) Singapore $0.095B 0.00
Neothetics (EVFM) United States $0.094B 0.00
Orgenesis (ORGS) United States $0.093B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.092B 0.00
Chiasma (CHMA) United States $0.090B 0.00
Cel-Sci (CVM) United States $0.089B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.089B 0.00
BioXcel Therapeutics (BTAI) United States $0.089B 0.00
Aptevo Therapeutics (APVO) United States $0.086B 0.00
Leap Therapeutics (LPTX) United States $0.085B 0.00
Checkpoint Therapeutics (CKPT) United States $0.084B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.084B 0.00
Protalix BioTherapeutics (PLX) Israel $0.084B 0.00
ScPharmaceuticals (SCPH) United States $0.083B 0.00
Prima BioMed (IMMP) Australia $0.083B 0.00
Ophthotech (OPHT) United States $0.082B 0.53
ITUS (ANIX) United States $0.081B 0.00
Cocrystal Pharma (COCP) United States $0.080B 0.00
NewLink Genetics (NLNK) United States $0.079B 0.00
Aptose Biosciences (APTO) Canada $0.074B 0.00
Vaccinex (VCNX) United States $0.072B 0.00
Trevena (TRVN) United States $0.071B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.070B 0.00
Sophiris Bio (SPHS) United States $0.069B 0.00
Evogene (EVGN) Israel $0.068B 0.00
Alimera Sciences (ALIM) United States $0.067B 0.00
BIONANO GENOMIC (BNGO) United States $0.066B 0.00
Entera Bio (ENTX) Israel $0.065B 0.00
Oncobiologics (ONS) United States $0.065B 0.00
Curis (CRIS) United States $0.064B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.063B 0.00
Celldex Therapeutics (CLDX) United States $0.060B 0.00
Alcobra (ARCT) United States $0.059B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.057B 0.00
VistaGen Therapeutics (VTGN) United States $0.056B 0.00
Oncolytics Biotech (ONCY) Canada $0.055B 0.00
Bellerophon Therapeutics (BLPH) United States $0.054B 0.00
Fortress Biotech (FBIO) United States $0.050B 0.00
Vascular Biogenics (VBLT) Israel $0.048B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.048B 0.00
Zosano Pharma (ZSAN) United States $0.048B 0.00
TRACON Pharmaceuticals (TCON) United States $0.045B 0.00
Asterias Biotherapeutics (AST) United States $0.045B 0.00
AZURRX BIOPHARM (AZRX) United States $0.045B 0.00
AquaBounty Technologies (AQB) United States $0.043B 0.00
Caladrius Biosciences (CLBS) United States $0.042B 0.00
GTx (GTXI) United States $0.042B 0.00
Celsion (CLSN) United States $0.041B 0.00
VIVUS (VVUS) United States $0.041B 0.00
Eyenovia (EYEN) United States $0.038B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.036B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.035B 0.00
Proteon Therapeutics (PRTO) United States $0.034B 0.00
BioPharmX (BPMX) United States $0.034B 0.00
Aileron Therapeutics (ALRN) United States $0.033B 0.00
Moleculin Biotech (MBRX) United States $0.033B 0.00
Advaxis (ADXS) United States $0.032B 0.00
Cellect Biotechnology (APOP) Israel $0.029B 0.00
Benitec Biopharma (BNTC) Australia $0.027B 0.00
CytRx (CYTR) United States $0.027B 0.00
OvaScience (OVAS) United States $0.027B 0.00
GENPREX INC (GNPX) United States $0.026B 0.00
Galena Biopharma (SLS) United States $0.026B 0.00
Vical (VICL) United States $0.026B 0.00
AEterna Zentaris (AEZS) United States $0.024B 48.33
Edge Therapeutics (EDGE) United States $0.024B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.021B 0.00
Arsanis (ASNS) United States $0.021B 0.00
Soligenix (SNGX) United States $0.020B 0.00
ATyr Pharma (LIFE) United States $0.020B 0.00
Histogenics (HSGX) United States $0.020B 0.00
Gemphire Therapeutics (GEMP) United States $0.020B 0.00
Novelion Therapeutics (NVLN) Canada $0.019B 0.00
Genetic Technologies (GENE) Australia $0.019B 0.00
TrovaGene (TROV) United States $0.019B 0.00
Cleveland BioLabs (CBLI) United States $0.019B 0.00
RestorGenex (DFFN) United States $0.018B 0.00
Fibrocell Science Inc (FCSC) United States $0.018B 0.00
Prana Biotechnology (PRAN) Australia $0.017B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.016B 0.00
Pulmatrix (PULM) United States $0.016B 0.00
Adial Pharmaceuticals (ADIL) United States $0.016B 0.00
Therapix Biosciences (TRPX) Israel $0.015B 5.74
IBio (IBIO) United States $0.015B 0.00
Oragenics (OGEN) United States $0.013B 0.00
Novogen (KZIA) Australia $0.012B 0.00
Vital Therapies (VTL) United States $0.012B 0.00
Neuralstem (CUR) United States $0.012B 0.00
Cerulean Pharma (DARE) United States $0.010B 0.00
Flex Pharma (FLKS) United States $0.010B 0.00
Hemispherx BioPharma (HEB) United States $0.010B 0.00
Alliqua BioMedical (ALQA) United States $0.010B 0.00
ARCA Biopharma (ABIO) United States $0.009B 0.00
MYOS RENS Technology (MYOS) United States $0.008B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.008B 0.00
Titan Pharmaceuticals (TTNP) United States $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
Stellar Biotechnologies (SBOT) United States $0.007B 0.00
Synthetic Biologics (SYN) United States $0.006B 0.00
AmpliPhi Biosciences (APHB) United States $0.005B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.003B 0.00
Aytu Bioscience (AYTU) United States $0.002B 0.00
Bio-Rad Laboratories (BIO.B) United States $0.000B 0.00
Y-MABS THERAPTC (YMAB) United States $0.000B 0.00